Related references
Note: Only part of the references are listed.Cryptotanshinone enhances neurite outgrowth and memory via extracellular signal-regulated kinase 1/2 signaling
Huiyoung Kwon et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Cryptotanshinone Suppresses Liver Fibrosis by Attenuating Epithelial-Mesenchymal Transition through Targeting Hedgehog Pathway
Shurong Ren et al.
Anti-Cancer Agents in Medicinal Chemistry (2020)
Attenuation of doxorubicin-induced cardiotoxicity by cryptotanshinone detected through association analysis of transcriptomic profiling and KEGG pathway
Le Li et al.
AGING-US (2020)
Cryptotanshinone from Salvia miltiorrhiza Bunge (Danshen) inhibited inflammatory responses via TLR4/MyD88 signaling pathway
Xin-Xing Li et al.
CHINESE MEDICINE (2020)
Cryptotanshinone reverses the epithelial-mesenchymal transformation process and attenuates bleomycin-induced pulmonary fibrosis
Qianyu Zhang et al.
PHYTOTHERAPY RESEARCH (2020)
Cryptotanshinone: A review of its pharmacology activities and molecular mechanisms
Yan-Hong Wu et al.
FITOTERAPIA (2020)
Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway
Yadong Liu et al.
JOURNAL OF CANCER (2020)
Cryptotanshinone from Salvia miltiorrhiza Roots Reduces Cytokeratin CK1/10 Expression in Keratinocytes by Activation of Peptidyl-prolyl-cis-trans-isomerase FKBP1A
Stefan Esch et al.
PLANTA MEDICA (2019)
Cryptotanshinone Ameliorates Radiation-Induced Lung Injury in Rats
Yifang Jiang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Activation of dynamin-related protein 1-dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone
Jia-Hau Yen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma
Shuo Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety
Jia Qiangqiang et al.
PHYTOMEDICINE (2019)
Cryptotanshinone Attenuates Oxygen-Glucose Deprivation/Recovery-Induced Injury in an in vitro Model of Neurovascular Unit
Hongye Zhao et al.
FRONTIERS IN NEUROLOGY (2019)
Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses
Zhen Han et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
The PTEN-PI3K Axis in Cancer
Antonella Papa et al.
BIOMOLECULES (2019)
Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways
Yuting Zhang et al.
PHARMACOLOGICAL RESEARCH (2019)
Cryptotanshinone Attenuates Inflammatory Response of Microglia Cells via the Nrf2/HO-1 Pathway
Yang Zhou et al.
FRONTIERS IN NEUROSCIENCE (2019)
The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer
Wenjuan Qin et al.
SCIENTIFIC REPORTS (2019)
Cryptotanshinone Attenuates Airway Remodeling by Inhibiting Crosstalk Between Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Transforming Growth Factor Beta 1 Signaling Pathways in Asthma
Chongyang Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cryptotanshinone Suppresses Non-Small Cell Lung Cancer via microRNA-146a-5p/EGFR Axis
Pengfei Qi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro
Jin Zeng et al.
ACTA PHARMACOLOGICA SINICA (2018)
Cryptotanshinone Attenuates Oxidative Stress and Inflammation through the Regulation of Nrf-2 and NF-kappa B in Mice with Unilateral Ureteral Obstruction
Wei Wang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3
Lipeng Tang et al.
EXPERIMENTAL DERMATOLOGY (2018)
Cryptotanshinone inhibits prostaglandin E2 production and COX-2 expression via suppression of TLR4/NF-κB signaling pathway in LPS-stimulated Caco-2 cells
Shu-guang Cao et al.
MICROBIAL PATHOGENESIS (2018)
Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's disease
Francesco Maione et al.
PHARMACOLOGICAL RESEARCH (2018)
Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis
Quanbo Ji et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Development of cryptotanshinone-loaded pellets for angina chronotherapy: In vitro/in vivo prediction and evaluation
Zhenghua Li et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation
Bowen Dong et al.
SCIENCE CHINA-LIFE SCIENCES (2018)
Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells
Yufei Yang et al.
CANCER MEDICINE (2018)
Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1 alpha nuclear translocation
Lin Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
Wenda Zhang et al.
CELL DEATH & DISEASE (2018)
PubChem BioAssay: 2017 update
Yanli Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Anti-tumor and chemosensitization effects of Cryptotanshinone extracted from Salvia miltiorrhiza Bge. on ovarian cancer cells in vitro
Guoqiang Jiang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity
Jiye Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Cryptotanshinone exhibits therapeutical effects on cerebral stroke through the PI3K/AKT-eNOS signaling pathway
Weixin Zhu et al.
MOLECULAR MEDICINE REPORTS (2017)
Cryptotanshinone Inhibits STAT3 Signaling to Alleviate Cardiac Fibrosis in Type 1-like Diabetic Rats
Shih-Hsiang Lo et al.
PHYTOTHERAPY RESEARCH (2017)
A novel topoisomerase 2a inhibitor, cryptotanshinone, suppresses the growth of PC3 cells without apparent cytotoxicity
Eun Ju Kim et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation
Liang Lu et al.
CELL DEATH & DISEASE (2017)
Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway
Ying Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases
Lili Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Cryptotanshinone promotes commitment to the brown adipocyte lineage and mitochondrial biogenesis in C3H10T1/2 mesenchymal stem cells via AMPK and p38-MAPK signaling
Khan Mohammad Imran et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
New cryptotanshinone derivatives with anti-influenza A virus activities obtained via biotransformation by Mucor rouxii
Wenni He et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
Therapeutic effect of Cryptotanshinone on experimental rheumatoid arthritis through downregulating p300 mediated-STAT3 acetylation
Ying Wang et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Cryptotanshinone induces ROS-dependent autophagy in multidrug-resistant colon cancer cells
Zhenyu Xu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
PI3K signaling in cancer: beyond AKT
Evan C. Lien et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated-STAT3 in vitro and in vivo
Li Shen et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells
Wenxing Chen et al.
BMC CANCER (2017)
Anticancer activity of cryptotanshinone on acute lymphoblastic leukemia cells
Ching-Fen Wu et al.
ARCHIVES OF TOXICOLOGY (2016)
G Cryptotanshinone, a Novel Tumor Angiogenesis Inhibitor, Destabilizes Tumor Necrosis Factor-α mRNA Via Decreasing Nuclear-Cytoplasmic Translocation of RNA-Binding Protein HuR
Zhijie Zhu et al.
MOLECULAR CARCINOGENESIS (2016)
Cryptotanshinone Induces Pro-death Autophagy through JNK Signaling Mediated by Reactive Oxygen Species Generation in Lung Cancer Cells
Wenhui Hao et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring
Yan Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion
Tinghong Ye et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Cryptotanshinone inhibits TNF-α-induced early atherogenic events in vitro
Zuraini Ahmad et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2016)
Cryptotanshinone inhibits TNF-α-induced LOX-1 expression by suppressing reactive oxygen species (ROS) formation in endothelial cells
Xiaoli Ran et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2016)
Cryptotanshinone, a compound of Salvia miltiorrhiza inhibits pre-adipocytes differentiation by regulation of adipogenesis-related genes expression via STAT3 signaling
Naimur Rahman et al.
PHYTOMEDICINE (2016)
Cryptotanshinone inhibits lung tumor growth by increasing CD4+ T cell cytotoxicity through activation of the JAK2/STAT4 pathway
Yonghong Man et al.
ONCOLOGY LETTERS (2016)
Cryptotanshinone-Loaded Cerasomes Formulation: In Vitro Drug Release, in Vivo Pharmacokinetics, and in Vivo Efficacy for Topical Therapy of Acne
Ting Zuo et al.
ACS OMEGA (2016)
Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway
Chen Xia et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells
Yuqing Ge et al.
LEUKEMIA & LYMPHOMA (2015)
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Jinlong Ru et al.
JOURNAL OF CHEMINFORMATICS (2014)
Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Wenxing Chen et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
DAVID-WS: a stateful web service to facilitate gene/protein list analysis
Xiaoli Jiao et al.
BIOINFORMATICS (2012)
A Novel Chemometric Method for the Prediction of Human Oral Bioavailability
Xue Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E
Yuqing Ge et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
Dae-Seop Shin et al.
CANCER RESEARCH (2009)
Structural elucidation of in vitro and in vivo metabolites of cryptotanshinone by HPLC-DAD-ESI-MSn
Haixue Dai et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Phytochemistry and pharmacognosy
J. David Phillipson
PHYTOCHEMISTRY (2007)
A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza
Jing Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Share Paper
